The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2025
Filed:
Mar. 20, 2020
Applicant:
The Regents of the University of California, Oakland, CA (US);
Inventors:
Michael E. Selsted, Pasadena, CA (US);
Dat Q. Tran, Alhambra, CA (US);
Assignee:
The Regents of the University of California, Oakland, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 9/00 (2006.01); A61K 38/10 (2006.01); A61K 38/12 (2006.01); A61K 38/55 (2006.01); C07K 14/47 (2006.01); F01P 5/04 (2006.01); F24F 5/00 (2006.01); F24F 6/16 (2006.01); B63J 3/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1729 (2013.01); A61K 9/0053 (2013.01); A61K 38/10 (2013.01); A61K 38/12 (2013.01); A61K 38/55 (2013.01); C07K 14/4723 (2013.01); F01P 5/04 (2013.01); F24F 5/0007 (2013.01); F24F 6/16 (2013.01); B63J 2003/002 (2013.01); F01P 2005/046 (2013.01); F24F 2203/1028 (2013.01); F24F 2203/1076 (2013.01);
Abstract
A method is provided for a condition related to the activity of a protease through the administration of a θ-defensin, analog, or derivative is described. Suitable proteases include metalloproteases and cysteine proteases such as Cathepsin-C. The θ-defensin, analog, or derivative can be effectively administered parenterally, topically, or orally.